Pseudomonas aeruginosa is a leading cause of hospital-acquired infections in the United
States. PqsE, a thioesterase enzyme, is vital for virulence of P. aeruginosa, making PqsE an …

The Pseudomonas aeruginosa genome can change to adapt to different ecological niches.
We compared four genomes from a Mexican hospital and 59 genomes from GenBank from …

Several variants of the plasmid-carried tigecycline resistance gene cluster, tmexCD-toprJ,
have been identified. This study characterized another novel variant, tmexC6D6-toprJ1b …

Introduction. Aminoglycoside antibiotics are widely used to treat infections of Pseudomonas
aeruginosa. The MexXY-OprM efflux pump is an important contributor to aminoglycoside …

This review outlines a literature‐based approach with illustrative examples of drug
repurposing (one molecule, multiple targets), which will be useful in tackling the problem of …

Objectives To characterize a novel acquired MBL, BIM-1, in a Pseudomonas# 2 (subgroup
P. guariconensis) strain isolated from the Aurá river located in the Brazilian Amazon …

The emergence of multidrug-resistant (MDR) pathogens has become a global public health
crisis. Among them, MDR Pseudomonas aeruginosa is the main cause of nosocomial …

Pseudomonas aeruginosa is noted for its intrinsic antibiotic resistance and capacity of
acquiring additional resistance genes. In this study, the genomes of nine clinical P …

Carbapenemases inactivate most β-lactam antibiotics, including carbapenems, and have
frequently been reported among Enterobacteriaceae, Acinetobacter spp. and Pseudomonas …

Ionic liquid (IL) based composite materials have shown great promise as antimicrobial
agents, owing to their inherent germicidal properties, as well as their ability to stabilize metal …